Locally invasive papillary thyroid carcinoma: 1940-1990
- PMID: 8021137
- DOI: 10.1002/hed.2880160211
Locally invasive papillary thyroid carcinoma: 1940-1990
Abstract
Well-differentiated thyroid carcinoma infrequently invades the upper aerodigestive tract. However, when invasion occurs, it is the source of significant morbidity. The most common structures invaded by thyroid carcinoma are the recurrent laryngeal nerves, larynx, pharynx, and esophagus. Invasion of these structures produces symptoms of airway insufficiency, dysphagia, and hemoptysis. This study was designed to define more clearly the significance of invasion of papillary thyroid carcinoma on survival. At the Mayo Clinic, 262 patients treated for invasive papillary thyroid carcinoma between 1940 and 1990 were retrospectively evaluated. In this group the sites of invasion were muscle 53%, trachea 37%, laryngeal nerve 47%, esophagus 21%, larynx 12%, and other sites 30%. Complete tumor removal was accomplished in 56% of cases. Kaplan-Meier survival curves were calculated for the population. The overall survival was 79% at 5 years, 63% at 10 years, and 54% at 15 years. When the Cox proportional hazard model was applied to the survival data, the factors that had significant influence on survival were invasion of the trachea and the esophagus. Completeness of resection approached statistical significance. Muscle invasion, laryngeal invasion, and recurrent laryngeal nerve invasion had no significant independent influence on survival. These data suggest that when papillary thyroid carcinoma extends beyond the thyroid capsule and invades adjacent structures, the site invaded will influence survival. Survival may be improved in those cases in which complete surgical excision of the tumor is performed.
Comment in
-
Treatment of extrathyroidal extension from papillary thyroid cancer.Head Neck. 1995 Jan-Feb;17(1):73. doi: 10.1002/hed.2880170116. Head Neck. 1995. PMID: 7883555 No abstract available.
Similar articles
-
Thyroid carcinoma invading the upper aerodigestive system.Laryngoscope. 1990 Aug;100(8):824-30. doi: 10.1288/00005537-199008000-00006. Laryngoscope. 1990. PMID: 2381258
-
[Invasive papillary thyroid carcinoma].Harefuah. 1994 Apr 15;126(8):433-8, 492. Harefuah. 1994. PMID: 8070721 Hebrew.
-
The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma.Arch Otolaryngol Head Neck Surg. 1997 May;123(5):484-90. doi: 10.1001/archotol.1997.01900050030003. Arch Otolaryngol Head Neck Surg. 1997. PMID: 9158394
-
Evaluation and treatment of aerodigestive tract invasion by well-differentiated thyroid carcinoma.Cancer Control. 2000 May-Jun;7(3):246-52. doi: 10.1177/107327480000700304. Cancer Control. 2000. PMID: 10832111 Review.
-
Prognosis and management of invasive well-differentiated thyroid cancer.Otolaryngol Clin North Am. 2010 Apr;43(2):301-28, viii. doi: 10.1016/j.otc.2010.02.002. Otolaryngol Clin North Am. 2010. PMID: 20510716 Review.
Cited by
-
Classification of aerodigestive tract invasion from thyroid cancer.Langenbecks Arch Surg. 2014 Feb;399(2):209-16. doi: 10.1007/s00423-013-1142-x. Epub 2013 Nov 24. Langenbecks Arch Surg. 2014. PMID: 24271275
-
Hypopharyngeal and parapharyngeal space metastasis of papillary thyroid carcinoma: a case report.Balkan Med J. 2014 Jun;31(2):177-9. doi: 10.5152/balkanmedj.2014.13003. Epub 2014 Jun 1. Balkan Med J. 2014. PMID: 25207192 Free PMC article.
-
Shaving Papillary Thyroid Carcinoma Involving Functioning Recurrent Laryngeal Nerve: Safety of Incomplete Tumor Resection and Nerve Sparing.Ann Surg Oncol. 2023 Nov;30(12):7157-7164. doi: 10.1245/s10434-023-14142-7. Epub 2023 Aug 21. Ann Surg Oncol. 2023. PMID: 37605083
-
Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland.Eur Arch Otorhinolaryngol. 2008 Oct;265(10):1155-60. doi: 10.1007/s00405-008-0728-3. Epub 2008 Jun 11. Eur Arch Otorhinolaryngol. 2008. PMID: 18546003 Review. No abstract available.
-
Preoperative voice analysis and survival outcomes in papillary thyroid cancer with recurrent laryngeal nerve invasion.Front Endocrinol (Lausanne). 2022 Oct 27;13:1041538. doi: 10.3389/fendo.2022.1041538. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387905 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical